| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 417,527 | 471,570 | 501,125 | 745,350 | | Cost of Revenue | 368,327 | 434,240 | 461,204 | 799,769 | | | Gross Profit | 49,200 | 37,330 | 39,921 | (54,419) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 50,025 | 50,526 | 47,778 | 48,340 | | Non Recurring | 3,626 | 6,044 | 16,309 | 108,879 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,451) | (19,240) | (24,166) | (211,638) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,695 | (1,779) | 5,004 | (1,260) | | Earnings Before Interest And Taxes | 13,388 | (12,287) | (15,348) | (201,865) | | Interest Expense | 2,511 | 4,326 | 4,289 | 6,550 | | Income Before Tax | 10,877 | (16,613) | (19,637) | (208,415) | | Income Tax Expense | 3,282 | (2,875) | (21,191) | (43,761) | | Minority Interest | (920) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,675 | (13,738) | 1,554 | (164,654) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,675 | (13,738) | 1,554 | (164,654) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,675 | ($13,738) | $1,554 | ($164,654) |
|
1.00% Nasdaq 
Income Statement
